Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline

被引：91

作者：

Newman, Connie B. ^{[1
]}

Blaha, Michael J. ^{[2
]}

Boord, Jeffrey B. ^{[3
,4
]}

Cariou, Bertrand ^{[5
]}

Chait, Alan ^{[6
]}

Fein, Henry G. ^{[7
]}

Ginsberg, Henry N. ^{[8
]}

Goldberg, Ira J. ^{[1
]}

Murad, M. Hassan ^{[9
]}

Subramanian, Savitha ^{[6
]}

Tannock, Lisa R. ^{[10
]}

机构：

[1] NYU, Grossman Sch Med, Div Endocrinol Diabet & Metab, Dept Med, New York, NY 10016 USA

[2] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21287 USA

[3] Parkview Hlth Syst, Dept Adm, Ft Wayne, IN 46845 USA

[4] Parkview Hlth Syst, Parkview Phys Grp, Endocrinol Sect, Ft Wayne, IN 46845 USA

[5] UNIV Nantes, CHU Nantes, CNRS, INSERM,Inst Thorax,Dept Endocrinol, F-44000 Nantes, France

[6] Univ Washington, Dept Med, Seattle, WA USA

[7] Sinai Hosp, Dept Med, Div Endocrinol, Baltimore, MD 21215 USA

[8] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, New York, NY 10032 USA

[9] Mayo Clin, Evidence Based Practice Ctr, Rochester, MN USA

[10] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2020年 / 105卷 / 12期

关键词：

endocrine diseases; lipids; triglycerides; cardiovascular disease; dyslipidemia; diabetes; POLYCYSTIC-OVARY-SYNDROME; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; GROWTH-HORMONE DEFICIENCY; TYPE-2; DIABETES-MELLITUS; GH-REPLACEMENT THERAPY; RENAL-TRANSPLANT RECIPIENTS; LIFE-STYLE INTERVENTION; ASSOCIATION TASK-FORCE;

D O I：

10.1210/clinem/dgaa674

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: This guideline will provide the practicing endocrinologist with an approach to the assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of preventing cardiovascular (CV) events and triglycerideinduced pancreatitis. The guideline reviews data on dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk in patients with endocrine disorders and discusses the evidence for the correction of dyslipidemia by treatment of the endocrine disease. The guideline also addresses whether treatment of the endocrine disease reduces ASCVD risk. Conclusion: This guideline focuses on lipid and lipoprotein abnormalities associated with endocrine diseases, including diabetes mellitus, and whether treatment of the endocrine disorder improves not only the lipid abnormalities, but also CV outcomes. Based on the available evidence, recommendations are made for the assessment and management of dyslipidemia in patients with endocrine diseases.

引用

页数：70

共 523 条

[1] Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities [J].

Abdu, TAM ;

Neary, R ;

Elhadd, TA ;

Akber, M ;

Clayton, RN .

CLINICAL ENDOCRINOLOGY, 2001, 55 (02) :209-216

[2] Weight and Metabolic Outcomes 12 Years after Gastric Bypass [J].

Adams, Ted D. ;

Davidson, Lance E. ;

Litwin, Sheldon E. ;

Kim, Jaewhan ;

Kolotkin, Ronette L. ;

Nanjee, M. Nazeem ;

Gutierrez, Jonathan M. ;

Frogley, Sara J. ;

Ibele, Anna R. ;

Brinton, Eliot A. ;

Hopkins, Paul N. ;

McKinlay, Rodrick ;

Simper, Steven C. ;

Hunt, Steven C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (12) :1143-1155

[3] Diabetic dyslipidaemia [J].

Adiels, Martin ;

Olofsson, Sven-Olof ;

Taskinen, Marja-Riitta ;

Boren, Jan .

CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (03) :238-246

[4] Efficacy of Colesevelam on Lowering Glycemia and Lipids [J].

Aggarwal, Saurabh ;

Loomba, Rohit S. ;

Arora, Rohit R. .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (02) :198-205

[5] Low serum testosterone in men is inversely associated with non-fasting serum triglycerides:: The Tromso study [J].

Agledahl, Ingvild ;

Skjaerpe, Paal-Ande ;

Hansen, John-Bjarne ;

Svartberg, Johan .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (04) :256-262

[6] Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index [J].

Akahoshi, M ;

Soda, M ;

Nakashima, E ;

Shimaoka, K ;

Seto, S ;

Yano, K .

CIRCULATION, 1996, 94 (01) :61-66

[7] Estrogen-associated severe hypertriglyceridemia with pancreatitis [J].

Aljenedil, Sumayah ;

Hegele, Robert A. ;

Genest, Jacques ;

Awan, Zuhier .

JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (01) :297-300

[8] Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome [J].

Alpanes, Macarena ;

Luque-Ramirez, Manuel ;

Angeles Martinez-Garcia, M. ;

Fernandez-Duran, Elena ;

Alvarez-Blasco, Francisco ;

Francisco Escobar-Morreale, Hector .

FERTILITY AND STERILITY, 2015, 103 (03) :795-U519

[9] A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke [J].

Amarenco, P. ;

Kim, J. S. ;

Labreuche, J. ;

Charles, H. ;

Abtan, J. ;

Bejot, Y. ;

Cabrejo, L. ;

Cha, J-K ;

Ducrocq, G. ;

Giroud, M. ;

Guidoux, C. ;

Hobeanu, C. ;

Kim, Y. J. ;

Lapergue, B. ;

Lavallee, P. C. ;

Lee, B-C ;

Lee, K-B ;

Leys, D. ;

Mahagne, M-H ;

Meseguer, E. ;

Nighoghossian, N. ;

Pico, F. ;

Samson, Y. ;

Sibon, I ;

Steg, P. G. ;

Sung, S-M ;

Touboul, P. J. ;

Touze, E. ;

Varenne, O. ;

Vicaut, E. ;

Yelles, N. ;

Bruckert, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :9-19

[10]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

← 1 2 3 4 5 6 7 8 9 10 →